Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

Overview of attention for article published in MMWR: Morbidity & Mortality Weekly Report, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 237 news outlets
blogs: 11 blogs
twitter: 2506 tweeters
facebook: 3 Facebook pages

wikipedia: 1 Wikipedia page
reddit: 3 Redditors
video: 3 video uploaders

Citations

dimensions_citation: 37 Dimensions

Summary News Blogs Twitter Facebook Wikipedia Reddit Video Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

Dynamics of Antibody Responses after Asymptomatic and Mild to Moderate SARS-CoV-2 Infections: Real-World Data in a Resource-Limited Country

Article in Tropical Medicine and Infectious Disease (March 2023)

Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women

Preprint in medRxiv (March 2023)

Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines – a matched cohort study in France

Preprint in medRxiv (March 2023)